Shifted balance of power in the US Congress following midterm elections could reshape federal spending priorities and increase regulatory scrutiny for public companies. Gains by opposition lawmakers could introduce broader oversight, legislative gridlock, and budget battles affecting sectors like defense, healthcare, and technology.
Historical equity trends show that a divided government often coincides with positive equity performance. Morgan Stanley research indicates the S&P 500 delivered an average gain of 23% in the year following midterms under a Republican president with a split Congress, compared with 16% when Democrats held both legislative chambers. However, market analysts warn that past historical market blueprints may not hold during this election cycle.
Government funding decisions remain a primary point of friction. The administration proposed $1.5 trillion in defense funding for fiscal 2027, along with an $87.6 billion supplemental request for fiscal 2026 tied mainly to operations in Iran. Defense contractors like Lockheed Martin obtain roughly 70% of revenue from government orders, leaving major hardware agreements dependent on congressional approval. In healthcare, nonpartisan estimates project $911 billion in Medicaid spending reductions through 2034, threatening revenue for managed care providers like Molina Healthcare, which relies on Medicaid for 75% of its premium earnings.